Willis Towers Watson plans to sell its TRANZACT Business for $632.4 million, expecting to incur non-cash impairment losses between $1.6 billion and $2.1 billion due to the write-down of assets. The transaction is expected to close by the end of 2024, pending regulatory approvals.